The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
mRNA Platform-Global Market Insights and Sales Trends 2024
Synopsis
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
The global mRNA Platform market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of mRNA Platform in various end use industries. The expanding demands from the Infectious Disease and Cancer, are propelling mRNA Platform market. Infectious Disease Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cancer Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for mRNA Platform market, driven by demand from China, the second largest economy with some signs of stabilising, the mRNA Platform market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for mRNA Platform, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global mRNA Platform market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global mRNA Platform market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, mRNA Platform sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of mRNA Platform covered in this report include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc.
The global mRNA Platform market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Global mRNA Platform market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global mRNA Platform market, Segment by Type:
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Platform market, by Application
Infectious Disease
Cancer
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of mRNA Platform companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
The global mRNA Platform market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of mRNA Platform in various end use industries. The expanding demands from the Infectious Disease and Cancer, are propelling mRNA Platform market. Infectious Disease Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cancer Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for mRNA Platform market, driven by demand from China, the second largest economy with some signs of stabilising, the mRNA Platform market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for mRNA Platform, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global mRNA Platform market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global mRNA Platform market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, mRNA Platform sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of mRNA Platform covered in this report include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc.
The global mRNA Platform market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Global mRNA Platform market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global mRNA Platform market, Segment by Type:
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Platform market, by Application
Infectious Disease
Cancer
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of mRNA Platform companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of mRNA Platform
1.1 mRNA Platform Market Overview
1.1.1 mRNA Platform Product Scope
1.1.2 mRNA Platform Market Status and Outlook
1.2 Global mRNA Platform Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global mRNA Platform Market Size by Region (2018-2029)
1.4 Global mRNA Platform Historic Market Size by Region (2018-2023)
1.5 Global mRNA Platform Market Size Forecast by Region (2024-2029)
1.6 Key Regions, mRNA Platform Market Size (2018-2029)
1.6.1 North America mRNA Platform Market Size (2018-2029)
1.6.2 Europe mRNA Platform Market Size (2018-2029)
1.6.3 Asia-Pacific mRNA Platform Market Size (2018-2029)
1.6.4 Latin America mRNA Platform Market Size (2018-2029)
1.6.5 Middle East & Africa mRNA Platform Market Size (2018-2029)
2 mRNA Platform Market by Type
2.1 Introduction
2.1.1 Infectious Disease Vaccines
2.1.2 Cancer Vaccines
2.2 Global mRNA Platform Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global mRNA Platform Historic Market Size by Type (2018-2023)
2.2.2 Global mRNA Platform Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America mRNA Platform Revenue Breakdown by Type (2018-2029)
2.3.2 Europe mRNA Platform Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific mRNA Platform Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America mRNA Platform Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa mRNA Platform Revenue Breakdown by Type (2018-2029)
3 mRNA Platform Market Overview by Application
3.1 Introduction
3.1.1 Infectious Disease
3.1.2 Cancer
3.2 Global mRNA Platform Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global mRNA Platform Historic Market Size by Application (2018-2023)
3.2.2 Global mRNA Platform Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America mRNA Platform Revenue Breakdown by Application (2018-2029)
3.3.2 Europe mRNA Platform Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific mRNA Platform Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America mRNA Platform Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa mRNA Platform Revenue Breakdown by Application (2018-2029)
4 mRNA Platform Competition Analysis by Players
4.1 Global mRNA Platform Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in mRNA Platform as of 2022)
4.3 Date of Key Players Enter into mRNA Platform Market
4.4 Global Top Players mRNA Platform Headquarters and Area Served
4.5 Key Players mRNA Platform Product Solution and Service
4.6 Competitive Status
4.6.1 mRNA Platform Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Arcturus Therapeutic
5.1.1 Arcturus Therapeutic Profile
5.1.2 Arcturus Therapeutic Main Business
5.1.3 Arcturus Therapeutic mRNA Platform Products, Services and Solutions
5.1.4 Arcturus Therapeutic mRNA Platform Revenue (US$ Million) & (2018-2023)
5.1.5 Arcturus Therapeutic Recent Developments
5.2 Argos Therapeutics
5.2.1 Argos Therapeutics Profile
5.2.2 Argos Therapeutics Main Business
5.2.3 Argos Therapeutics mRNA Platform Products, Services and Solutions
5.2.4 Argos Therapeutics mRNA Platform Revenue (US$ Million) & (2018-2023)
5.2.5 Argos Therapeutics Recent Developments
5.3 BioNTec
5.3.1 BioNTec Profile
5.3.2 BioNTec Main Business
5.3.3 BioNTec mRNA Platform Products, Services and Solutions
5.3.4 BioNTec mRNA Platform Revenue (US$ Million) & (2018-2023)
5.3.5 CureVac Recent Developments
5.4 CureVac
5.4.1 CureVac Profile
5.4.2 CureVac Main Business
5.4.3 CureVac mRNA Platform Products, Services and Solutions
5.4.4 CureVac mRNA Platform Revenue (US$ Million) & (2018-2023)
5.4.5 CureVac Recent Developments
5.5 Etherna
5.5.1 Etherna Profile
5.5.2 Etherna Main Business
5.5.3 Etherna mRNA Platform Products, Services and Solutions
5.5.4 Etherna mRNA Platform Revenue (US$ Million) & (2018-2023)
5.5.5 Etherna Recent Developments
5.6 Ethris
5.6.1 Ethris Profile
5.6.2 Ethris Main Business
5.6.3 Ethris mRNA Platform Products, Services and Solutions
5.6.4 Ethris mRNA Platform Revenue (US$ Million) & (2018-2023)
5.6.5 Ethris Recent Developments
5.7 GlaxoSmithKline
5.7.1 GlaxoSmithKline Profile
5.7.2 GlaxoSmithKline Main Business
5.7.3 GlaxoSmithKline mRNA Platform Products, Services and Solutions
5.7.4 GlaxoSmithKline mRNA Platform Revenue (US$ Million) & (2018-2023)
5.7.5 GlaxoSmithKline Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer mRNA Platform Products, Services and Solutions
5.8.4 Pfizer mRNA Platform Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Translate Bio
5.9.1 Translate Bio Profile
5.9.2 Translate Bio Main Business
5.9.3 Translate Bio mRNA Platform Products, Services and Solutions
5.9.4 Translate Bio mRNA Platform Revenue (US$ Million) & (2018-2023)
5.9.5 Translate Bio Recent Developments
6 North America
6.1 North America mRNA Platform Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe mRNA Platform Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific mRNA Platform Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America mRNA Platform Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa mRNA Platform Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 mRNA Platform Market Dynamics
11.1 mRNA Platform Industry Trends
11.2 mRNA Platform Market Drivers
11.3 mRNA Platform Market Challenges
11.4 mRNA Platform Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
